De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

SIGA Technologies Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Diem Nguyen

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	7.2yrs
Gemiddelde ambtstermijn bestuur	3.6yrs

Recente managementupdates

Recent updates

SIGA Technologies, Inc. (NASDAQ:SIGA) Not Doing Enough For Some Investors As Its Shares Slump 34%

Sep 14

SIGA Technologies: Shares Tanking On Mpox Study Miss, Turbulence May Be Temporary

Aug 15

SIGA Technologies, Inc. (NASDAQ:SIGA) Held Back By Insufficient Growth Even After Shares Climb 31%

Jul 14

SIGA Technologies: BARDA Contract Renewal Required To Sustain Recent Momentum (Rating Downgrade)

Jun 13

SIGA Technologies, Inc. (NASDAQ:SIGA) Stock Rockets 64% But Many Are Still Ignoring The Company

Mar 31

Siga Technologies: Preparing For A Contingency If Tomorrow Comes

Mar 25

Shareholders Can Be Confident That SIGA Technologies' (NASDAQ:SIGA) Earnings Are High Quality

Mar 19

SIGA to activate first trial sites for monkeypox therapy in U.K. next week – Bloomberg

Aug 17

Estimating The Fair Value Of SIGA Technologies, Inc. (NASDAQ:SIGA)

Aug 12

SIGA to deliver $26M of monkeypox therapy to U.S. in 2023 after option exercise

Aug 09

SIGA Technologies: Unjustified Selloff, Loading The Boat, Best Monkeypox Play

Aug 01

SIGA Technologies: Buy Monkeypox

Jul 25

Siga Technologies receives approval from UK for tecovirimat

Jul 08

SIGA Technologies: Solid Business With Means To Address Monkeypox Outbreak

May 27

SIGA Technologies: There's An Assured Market For A Smallpox Vaccine

Dec 12

It's Probably Less Likely That SIGA Technologies, Inc.'s (NASDAQ:SIGA) CEO Will See A Huge Pay Rise This Year

Jun 08

SIGA Technologies: Biodefense Pharma Unlocks New Value Abroad For TPOXX

Apr 28

Introducing SIGA Technologies (NASDAQ:SIGA), The Stock That Soared 880% In The Last Five Years

Feb 22

We're Not So Sure You Should Rely on SIGA Technologies' (NASDAQ:SIGA) Statutory Earnings

Feb 02

CEO

Diem Nguyen (52 yo)

less than a year

Tenure

Dr. Diem Nguyen, Ph D., M.B.A., is Chief Executive Officer and Director of SIGA Technologies, Inc. from January 27, 2024. Dr. Nguyen joined the SIGA Technologies, Inc. on January 27, 2024.She serves as an...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Daniel Luckshire	Executive VP	13.7yrs	US$1.72m	0.37% $ 1.8m
Dennis Hruby	Executive VP & Chief Scientific Officer	24.3yrs	US$1.81m	0.24% $ 1.2m
Diem Nguyen	CEO & Director	less than a year	geen gegevens	geen gegevens
Tove Bolken	Senior VP of Operations & Chief Supply Chain Officer	no data	geen gegevens	geen gegevens
Herb Vloedman	Senior VP & Chief Information Officer	no data	geen gegevens	geen gegevens
Lawrence Miller	General Counsel	less than a year	geen gegevens	0.043% $ 215.1k

7.2yrs

Gemiddelde duur

54.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van SIGA is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.2 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Diem Nguyen	CEO & Director	less than a year	geen gegevens	geen gegevens
Jaymie Durnan	Independent Director	4.3yrs	US$206.58k	0.082% $ 407.3k
Joseph Marshall	Independent Director	15.6yrs	US$227.07k	0.30% $ 1.5m
Julian Nemirovsky	Independent Director	3.8yrs	US$218.32k	0.061% $ 302.9k
Harold Ford	Independent Director	1.9yrs	US$200.50k	0.024% $ 120.4k
Gary Nabel	Independent Director	3.3yrs	US$209.08k	0.061% $ 302.9k
Evan Knisely	Director	no data	US$537.10k	0.038% $ 190.2k
Holly Phillips	Independent Director	3.6yrs	US$210.33k	0.061% $ 302.9k

3.6yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van SIGA wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).

SIGA Technologies Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

SIGA Technologies, Inc., Annual General Meeting, Jun 11, 2024

High number of new directors

Siga Technologies, Inc. Appoints Diem Nguyen to the Board of Directors

SIGA Technologies, Inc. Appoints Jay K. Varma as EVP and Chief Medical Officer

SIGA Technologies Announces Planned Retirement of CEO Phil Gomez in 2023

High number of new directors

Recent updates

SIGA Technologies, Inc. (NASDAQ:SIGA) Not Doing Enough For Some Investors As Its Shares Slump 34%

SIGA Technologies: Shares Tanking On Mpox Study Miss, Turbulence May Be Temporary

SIGA Technologies, Inc. to Report Q2, 2024 Results on Aug 01, 2024

SIGA Technologies, Inc. (NASDAQ:SIGA) Held Back By Insufficient Growth Even After Shares Climb 31%

SIGA Technologies: BARDA Contract Renewal Required To Sustain Recent Momentum (Rating Downgrade)

First quarter 2024 earnings released: EPS: US$0.14 (vs US$0.013 loss in 1Q 2023)

New minor risk - Share price stability

Investor sentiment improves as stock rises 15%

SIGA Technologies, Inc. to Report Q1, 2024 Results on May 07, 2024

SIGA Technologies, Inc., Annual General Meeting, Jun 11, 2024

New major risk - Revenue and earnings growth

Investor sentiment improves as stock rises 17%

SIGA Technologies, Inc. (NASDAQ:SIGA) Stock Rockets 64% But Many Are Still Ignoring The Company

Siga Technologies: Preparing For A Contingency If Tomorrow Comes

Shareholders Can Be Confident That SIGA Technologies' (NASDAQ:SIGA) Earnings Are High Quality

Investor sentiment improves as stock rises 63%

Upcoming dividend of US$0.60 per share

Full year 2023 earnings: EPS and revenues miss analyst expectations

Siga Technologies, Inc. Declares A Special Cash Dividend, Payable on April 11, 2024

SIGA Technologies, Inc. to Report Q4, 2023 Results on Mar 12, 2024

The Price Is Right For SIGA Technologies, Inc. (NASDAQ:SIGA)

High number of new directors

New major risk - Revenue and earnings growth

Siga Technologies, Inc. Appoints Diem Nguyen to the Board of Directors

Third quarter 2023 earnings released: US$0.006 loss per share (vs US$0.45 profit in 3Q 2022)

SIGA Technologies, Inc. to Report Q3, 2023 Results on Nov 07, 2023

SIGA Technologies, Inc. Appoints Jay K. Varma as EVP and Chief Medical Officer

Second quarter 2023 earnings released: US$0.04 loss per share (vs US$0.028 profit in 2Q 2022)

SIGA Technologies, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Inaugural dividend of US$0.45 per share

First quarter 2023 earnings released: US$0.013 loss per share (vs US$0.005 loss in 1Q 2022)

SIGA Technologies, Inc. Declares a Special Cash Dividend, Payable on June 1, 2023

Investor sentiment deteriorates as stock falls 18%

Full year 2022 earnings: EPS and revenues miss analyst expectations

SIGA Technologies Announces Planned Retirement of CEO Phil Gomez in 2023

Investor sentiment improved over the past week

Do SIGA Technologies' (NASDAQ:SIGA) Earnings Warrant Your Attention?

High number of new directors

SIGA Technologies, Inc. Announces Directorate Appointments

Third quarter 2022 earnings released: EPS: US$0.45 (vs US$0.042 loss in 3Q 2021)

SIGA Technologies, Inc. to Report Q3, 2022 Results on Nov 03, 2022

SIGA Technologies, Inc. Provides Update on Progress in Clinical Trials to Assess Use of Tpoxx ® (Tecovirimat) for Treatment of Monkeypox

SIGA Technologies secures new contract awarded to procure up to $10.7M of TPOXX

Investor sentiment deteriorated over the past week

Siga monkeypox therapy undergoes NIH-led late-stage trial

Investor sentiment deteriorated over the past week

Scientists behind key COVID study run monkeypox trial for SIGA therapy

Now 21% undervalued

SIGA to activate first trial sites for monkeypox therapy in U.K. next week – Bloomberg

Estimating The Fair Value Of SIGA Technologies, Inc. (NASDAQ:SIGA)

SIGA to deliver $26M of monkeypox therapy to U.S. in 2023 after option exercise

James Antal Provides Notice to SIGA Technologies, Inc. of His Resignation from the Board of Directors

Second quarter 2022 earnings released: EPS: US$0.028 (vs US$0.002 in 2Q 2021)

SIGA Technologies: Unjustified Selloff, Loading The Boat, Best Monkeypox Play

SIGA Technologies, Inc. to Report Q2, 2022 Results on Aug 04, 2022

SIGA Technologies: Buy Monkeypox

Investor sentiment improved over the past week

SIGA Technologies Receives Approval from UK for Tecovirimat

Siga Technologies receives approval from UK for tecovirimat

SIGA Technologies, Inc.(NasdaqGM:SIGA) dropped from Russell 2000 Growth-Defensive Index

Investor sentiment improved over the past week

Independent Director exercised options and sold US$70k worth of stock

Investor sentiment improved over the past week

SIGA Technologies: Solid Business With Means To Address Monkeypox Outbreak

SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat)

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS exceeds analyst expectations

SIGA Technologies, Inc. Declares a Special Dividend of the Company, Payable on June 2, 2022

High number of new directors